Long-term risk of sustained hypertension in white-coat or masked hypertension

Hypertension

Volumn 54, Issue 2, 2009, Pages 226-232

  Mancia, Giuseppe ^a,c   Bombelli, Michele ^a   Facchetti, Rita ^a   Madotto, Fabiana ^b   Quarti Trevano, Fosca ^a   Friz, Hernan Polo ^b   Grassi, Guido ^a   Sega, Roberto ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b IRCCS MULTIMEDICA   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

Author keywords

Ambulatory blood pressure monitoring; Masked hypertension; Prognosis; White coat hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; AMBULATORY MONITORING; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CLINICAL EXAMINATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HOME MONITORING; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MASKED HYPERTENSION; PRIORITY JOURNAL; PROGNOSIS; RISK; SUSTAINED HYPERTENSION; SYSTOLIC BLOOD PRESSURE; WHITE COAT HYPERTENSION; AGE; AMBULATORY CARE; ANALYSIS OF VARIANCE; BLOOD; BLOOD PRESSURE MEASUREMENT; BODY MASS; CASE CONTROL STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; DOCTOR PATIENT RELATION; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROBABILITY; REFERENCE VALUE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SURVIVAL; TIME;

ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OFFICE VISITS; PHYSICIAN-PATIENT RELATIONS; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 68549101825     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.129882     Document Type: Article

References (23)

1. Messerli FH, Cotiga D. Masked hypertension and white-coat hypertension: therapeutic navigation between scylla and charybdis. J Am Coll Cardiol. 2005;46:516-517.
2. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, for the ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105-1187.
3. Verdecchia P, Angeli F, Gattobigio R, Borgioni C, Castellani C, Sardone M, Reboldi G. The clinical significance of white-coat and masked hypertension. Blood Press Monit. 2007;12:387-389.
4. Ribeiro L, Gama G, Santos A, Asmar R, Martins L, Polónia J. Arterial distensibility in subjects with white-coat hypertension with and without diabetes or dyslipidaemia: comparison with normotensives and sustained hypertensives. Blood Press Monit. 2000;5:11-17.
5. Silva JA, Barbosa L, Bertoquini S, Maldonado J, Polónia J. Relationship between aortic stiffness and cardiovascular risk factors in a population of normotensives, white-coat normotensives, white-coat hypertensives, sustained hypertensives and diabetic patients. Rev Port Cardiol. 2004;23: 1533-1547.
6. Stabouli S, Kotsis V, Toumanidis S, Papamichael C, Constantopoulos A, Zakopoulos N. White-coat and masked hypertension in children: association with target-organ damage. Pediatr Nephrol. 2005;20:1151-1155.
7. Bobrie G, Clerson P, Ménard J, Postel-Vinay N, Chatellier G, Plouin PF. Masked hypertension: a systematic review. J Hypertens. 2008;26: 1715-1725.
8. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Porcellati C. Prognostic significance of the white coat effect. Hypertension. 1997;29:1218-1224.
9. Khattar RS, Swales JD, Banfield A, Dore C, Senior R, Lahiri A. Prediction of coronary and cerebrovascular morbidity and mortality by direct continuous ambulatory blood pressure monitoring in essential hypertension. Circulation. 1999;100:1071-1076.
10. Celis H, Staessen JA, Thijs L, Buntinx F, De Buyzere M, Den Hond E, Fagard RH, O'Brien ET, for the Ambulatory Blood Pressure and Treatment of Hypertension Trial Investigators. Cardiovascular risk in white-coat and sustained hypertensive patients. Blood Press. 2002;11: 352-356.
11. Fagard RH, Van Den Broeke C, De Cort P. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens. 2005;19:801-807.
12. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006;47:846-853.
13. Hansen TW, Kikuya M, Thijs L, Björklund-Bodegård K, Kuznetsova T, Ohkubo T, Richart T, Torp-Pedersen C, Lind L, Jeppesen J, Ibsen H, Imai Y, Staessen JA. Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7030 individuals. J Hypertens. 2007;25:1554-1564.
14. Pickering TG, Eguchi K, Kario K. Masked hypertension: a review. Hypertens Res. 2007;30:479-488.
15. Sega R, Cesana G, Milesi C, Grassi G, Zanchetti A, Mancia G. Ambulatory and home blood pressure normality in the elderly: data from the PAMELA population. Hypertension. 1997;30:1-6.
16. WHO-MONICA Project Principal Investigators. The World Health Organization Monica Project: a major international collaboration. J Clin Epidemiol. 1998;41:105-114.
17. Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Quarti Trevano F, Grassi G, Sega R. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension. 2007;49: 1265-1270.
18. Volpe M, Tocci G, Trimarco B, Rosei EA, Borghi C, Ambrosioni E, Menotti A, Zanchetti A, Mancia G. Blood pressure control in Italy: results of recent surveys on hypertension. J Hypertens. 2007;25:1491-1498.
19. Mancia G, Bombelli M, Lanzarotti A, Grassi G, Cesana G, Zanchetti A, Sega R. Systolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni. Arch Intern Med. 2002;162:582-586.
20. Kotsis V, Stabouli S, Toumanidis S, Papamichael C, Lekakis J, Germanidis G, Hatzitolios A, Rizos Z, Sion M, Zakopoulos N. Target organ damage in "white coat hypertension" and "masked hypertension." Am J Hypertens. 2008;21:393-399.
21. Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension. 2008;51:55-61.
22. Verdecchia P, Angeli F, Sardone M, Borgioni C, Garofoli M, Reboldi G. Is the definition of daytime and nighttime blood pressure prognostically relevant? Blood Press Monit. 2008;13:153-155.
23. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-hour blood pressure variability. J Hypertens. 1993;11:1133-1137.